Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 10, 2023
Clinical impact of preservation fluid contamination on kidney transplant patientsNatalia Picola Brau, Maria Fiol Riera, Begoña Etcheverry Giadrosich, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2014
Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipientsMarc Lúcia, Elena Crespo, Edoardo Melilli, et al.Clinical Kidney Journal|November 3, 2022
Effect of kidney replacement therapy modality after first kidney graft failure on second kidney transplantation outcomesCarlos Couceiro, Inés Rama, Jordi Comas, et al.Transplantation|August 22, 2018
CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction TherapyMarta Jarque, Edoardo Melilli, Elena Crespo, et al.Clinical Transplantation|May 22, 2020
Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidismPablo Moreno, Ana Coloma, José V Torregrosa, et al.Kidney International|July 16, 2015
Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantationMarc Lúcia, Sergi Luque, Elena Crespo, et al.The Cochrane Database of Systematic Reviews|April 8, 2025
Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients at high risk of delayed graft functionLaia Oliveras, Pamela López-Vargas, Edoardo Melilli, et al.Clinical Kidney Journal|July 20, 2021
Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19Paula Anton Pampols, Hernando Trujillo, Edoardo Melilli, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 2010
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agentsNicola Tessitore, Domenico Girelli, Natascia Campostrini, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 4, 2026
Normothermic regional perfusion in kidney transplants with donors after controlled circulatory death: Functional benefits and safety in older recipientsNéstor Toapanta, Jordi Comas, Fritz Diekmann, et al.Pageof 9